Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Inventory Average (2012 - 2026)

Kamada's (KMDA) quarterly Inventory Average came in at $86.2 million in Q2 2026, up 7.4% on a YoY basis from $80.2 million in Q2 2025, and up 1.13% quarter-over-quarter from $85.2 million in Q1 2026.

Analysis

Kamada (KMDA) Inventory Average (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Inventory Average for 15 consecutive years, with $86.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Inventory Average rose 7.4% year-over-year to $86.2 million; the trailing twelve-month figure through Jun 2026 stood at $86.2 million (up 7.4% YoY), and the FY2025 full-year result was $81.9 million, down 2.11% from the prior year.
  • Inventory Average advanced to $86.2 million in Q2 2026 per KMDA's latest filing, from $85.2 million in the prior quarter.
  • Across five years, Inventory Average topped out at $86.4 million in Q1 2024 and bottomed at $64.6 million in Q2 2022.
  • Historically, Inventory Average has averaged $77.8 million across 5 years, with a median of $79.3 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Inventory Average jumped 58.93% in 2022, then slipped 9.06% in 2025.
  • Over 5 years, Inventory Average stood at $70.9 million in 2022, then grew by 14.43% to $81.1 million in 2023, then decreased by 7.33% to $75.2 million in 2024, then advanced by 13.29% to $85.2 million in 2025, then increased by 1.15% to $86.2 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods registered $86.2 million, $85.2 million, and $85.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Amgen 211.30 Bn 197.31 Bn 7.24 Bn 6.20 Bn
2 Gilead Sciences 180.97 Bn 177.79 Bn 6.22 Bn 1.93 Bn
3 Vertex Pharmaceuticals 132.27 Bn 124.42 Bn 2.84 Bn 1.77 Bn
4 Regeneron Pharmaceuticals 82.93 Bn 74.93 Bn 3.93 Bn 3.09 Bn
5 Argenx Se 61.53 Bn 56.35 Bn 1.37 Bn -
6 Moderna 54.27 Bn 49.13 Bn 52.00 Mn 213.00 Mn
7 Alnylam Pharmaceuticals 34.46 Bn 31.15 Bn 992.69 Mn 90.57 Mn
8 Biogen 31.16 Bn 29.88 Bn 1.96 Bn 2.17 Bn
9 Roivant Sciences 30.08 Bn 30.08 Bn 1.16 Mn -
10 Kamada 473.85 Mn 403.72 Mn 22.47 Mn 86.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86.16 Mn
Mar 31, 2026 85.19 Mn
Dec 31, 2025 85.18 Mn
Sep 30, 2025 83.75 Mn
Jun 30, 2025 80.22 Mn
Mar 31, 2025 78.59 Mn
Dec 31, 2024 75.19 Mn
Sep 30, 2024 75.14 Mn
Jun 30, 2024 81.53 Mn
Mar 31, 2024 86.41 Mn
Dec 31, 2023 81.14 Mn
Sep 30, 2023 77.02 Mn
Jun 30, 2023 80.00 Mn
Mar 31, 2023 74.27 Mn
Dec 31, 2022 70.91 Mn
Sep 30, 2022 68.77 Mn
Jun 30, 2022 64.64 Mn
Mar 31, 2022 66.09 Mn
Dec 31, 2021 57.79 Mn
Sep 30, 2021 46.38 Mn